Oncolytics Biotech INC
SEC CIK 1129928 · ONCY · last insider filing 2026-06-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Glover Steve C | Director | filed 2026 - 2026 |
| Rigby Jonathan | Director | filed 2026 - 2026 |
| Andrews Patricia S | Director | filed 2026 - 2026 |
| Pisano Wayne | Director | filed 2026 - 2026 |
| Parsons James T. | Director | filed 2026 - 2026 |
| Seizinger Bernd R. | Director | filed 2026 - 2026 |
| Holtham Angela | Director | filed 2026 - 2026 |
| Brown Deborah Margaret | Director | filed 2026 - 2026 |
| Kelly Jared | Director · Chief Executive Officer | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Aromando Andrew | Chief Business Officer | filed 2026 - 2026 |
| Heineman Thomas Charles | Chief Medical Officer | filed 2026 - 2026 |
| Look Kirk | Chief Financial Officer | filed 2026 - 2026 |
| Hagerman Allison | VP, Product Development | filed 2026 - 2026 |
| Mcadory John Bearden | Chief Operating Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.